This method continues to be useful for alemtuzumab (anti-CD52) but is difficult to build up, requires skilled personnel to execute, and has limited sensitivity [8]
This method continues to be useful for alemtuzumab (anti-CD52) but is difficult to build up, requires skilled personnel to execute,…